A Randomized, Double-Blind Placebo-Controlled Exploration of a Topical Menadione-Containing Lotion to the Face for Prevention and Palliation of Epidermal Growth Factor Receptor Inhibitor-Induced Cutaneous Discomfort and Psychological Distress
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Menadione (Primary)
- Indications Exanthema
- Focus Therapeutic Use
- 21 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 21 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 07 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.